ATA178285A - Verfahren zur herstellung eines neuen antitumor-antibiotikums und seine verwendung - Google Patents

Verfahren zur herstellung eines neuen antitumor-antibiotikums und seine verwendung

Info

Publication number
ATA178285A
ATA178285A AT0178285A AT178285A ATA178285A AT A178285 A ATA178285 A AT A178285A AT 0178285 A AT0178285 A AT 0178285A AT 178285 A AT178285 A AT 178285A AT A178285 A ATA178285 A AT A178285A
Authority
AT
Austria
Prior art keywords
producing
antitumor antibiotic
new antitumor
new
antibiotic
Prior art date
Application number
AT0178285A
Other languages
English (en)
Other versions
AT395860B (de
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of ATA178285A publication Critical patent/ATA178285A/de
Application granted granted Critical
Publication of AT395860B publication Critical patent/AT395860B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00Peptide or protein sequence
    • Y10S930/01Peptide or protein sequence
    • Y10S930/19Antibiotic
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00Peptide or protein sequence
    • Y10S930/01Peptide or protein sequence
    • Y10S930/27Cyclic peptide or cyclic protein

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
AT0178285A 1984-06-18 1985-06-14 Verfahren zur herstellung eines neuen antitumor-antibiotikums und seine verwendung AT395860B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/621,641 US4582639A (en) 1984-06-18 1984-06-18 Antitumor antibiotic compound

Publications (2)

Publication Number Publication Date
ATA178285A true ATA178285A (de) 1992-08-15
AT395860B AT395860B (de) 1993-03-25

Family

ID=24491001

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0178285A AT395860B (de) 1984-06-18 1985-06-14 Verfahren zur herstellung eines neuen antitumor-antibiotikums und seine verwendung

Country Status (23)

Country Link
US (1) US4582639A (de)
JP (1) JPS6122099A (de)
KR (1) KR930003107B1 (de)
AT (1) AT395860B (de)
AU (1) AU584075B2 (de)
BE (1) BE902670A (de)
CA (1) CA1230568A (de)
CH (1) CH668974A5 (de)
DE (1) DE3521436A1 (de)
DK (1) DK272985A (de)
ES (1) ES8609485A1 (de)
FI (1) FI80475C (de)
FR (1) FR2568892B1 (de)
GB (1) GB2160529B (de)
GR (1) GR851452B (de)
IE (1) IE58629B1 (de)
IT (1) IT1191622B (de)
LU (1) LU85953A1 (de)
MY (1) MY100478A (de)
NL (1) NL8501708A (de)
PT (1) PT80656B (de)
SE (1) SE464524B (de)
ZA (1) ZA852370B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4902781A (en) * 1987-11-24 1990-02-20 Taisho Pharmaceutical Co., Ltd. Novel tripetide derivatives
DE3832362A1 (de) * 1988-09-23 1990-03-29 Sandoz Ag Neue cyclopeptolide, verfahren zu ihrer herstellung und ihre verwendung
US5516676A (en) * 1993-06-15 1996-05-14 Bristol-Myers Squibb Company Preparation of C-13 hydroxyl-bearing taxanes using nocardioides or a hydrolase isolated therefrom
US5523219A (en) * 1993-06-15 1996-06-04 Bristol-Myers Squibb Company Enzymatic hydrolysis method for the preparation of C-10 hydroxyl-bearing taxanes and enzymatic esterification method for the preparation of C-10 acyloxy-bearing
US5643871A (en) * 1993-11-23 1997-07-01 Bristol-Meyers Squibb Company Antitumor antibiotics
US5444043A (en) * 1994-02-18 1995-08-22 The Regents Of The University Of California Cyclic heptapeptide anti-inflammatory agent
GB2294265A (en) * 1994-10-20 1996-04-24 Merck & Co Inc Cyclic depsipeptides obtained from Actinomycete sp.
CA2285259A1 (en) * 1997-03-28 1998-10-08 The Scripps Research Institute Sandramycin analogs
US6001815A (en) * 1997-12-25 1999-12-14 Nisshin Flour Milling Co., Ltd. Depsipeptides containing N-substituted glycine residue
KR100575681B1 (ko) 2004-05-18 2006-05-03 엘지전자 주식회사 와인 냉장고의 진동절연 지지장치
EP1924245A2 (de) * 2005-08-19 2008-05-28 Government of the United States of America, Represented by the Secretary, Department of Health and Human Services Topische formulierungen von histondeacetylase-hemmern und verfahren zur verwendung derselben

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4451456A (en) * 1979-04-02 1984-05-29 Bristol-Myers Company Antitumor antibacterial agents
US4360458A (en) * 1979-04-02 1982-11-23 Bristol-Myers Company Antitumor antibacterial agents

Also Published As

Publication number Publication date
CA1230568A (en) 1987-12-22
ZA852370B (en) 1985-11-27
SE8502996L (sv) 1985-12-19
KR930003107B1 (ko) 1993-04-19
LU85953A1 (fr) 1986-01-24
PT80656A (en) 1985-07-01
DK272985A (da) 1985-12-19
NL8501708A (nl) 1986-01-16
GR851452B (de) 1985-11-25
BE902670A (fr) 1985-12-17
AU4048085A (en) 1986-01-02
ES8609485A1 (es) 1986-09-01
DE3521436A1 (de) 1985-12-19
IE851504L (en) 1985-12-18
FI80475B (fi) 1990-02-28
DE3521436C2 (de) 1993-08-05
IT8521156A0 (it) 1985-06-14
FI852082L (fi) 1985-12-19
IT1191622B (it) 1988-03-23
AU584075B2 (en) 1989-05-18
GB2160529B (en) 1987-10-07
JPH0158200B2 (de) 1989-12-11
GB8515256D0 (en) 1985-07-17
AT395860B (de) 1993-03-25
IE58629B1 (en) 1993-10-20
US4582639A (en) 1986-04-15
PT80656B (pt) 1988-01-22
CH668974A5 (de) 1989-02-15
DK272985D0 (da) 1985-06-17
JPS6122099A (ja) 1986-01-30
SE8502996D0 (sv) 1985-06-17
SE464524B (sv) 1991-05-06
FI852082A0 (fi) 1985-05-24
ES544289A0 (es) 1986-09-01
GB2160529A (en) 1985-12-24
KR860000382A (ko) 1986-01-28
MY100478A (en) 1990-10-15
FI80475C (fi) 1990-06-11
FR2568892B1 (fr) 1990-02-09
FR2568892A1 (fr) 1986-02-14

Similar Documents

Publication Publication Date Title
AT386196B (de) Verfahren zur herstellung eines neuen indolderivates und seiner salze
ATA20485A (de) Verfahren zur herstellung von neuen tetrahydrocarbazol-derivaten
ATA115486A (de) Verfahren zur herstellung neuer antibiotischer makrolite
AT381941B (de) Verfahren zur herstellung eines neuen carbapenem-antibiotikums
ATA289189A (de) Verfahren zur herstellung eines antibiotikums
ATA178285A (de) Verfahren zur herstellung eines neuen antitumor-antibiotikums und seine verwendung
DE3679776D1 (de) Verfahren zur herstellung und verwendung eines silberkatalysators.
ATA337185A (de) Verfahren zur herstellung neuer flavolignanderivate
AT362059B (de) Verfahren zur herstellung eines neuen antibiotikums und seiner derivate
ATA273486A (de) Verfahren zur herstellung von neuen dichloranilinderivaten
ATA124285A (de) Verfahren zur herstellung neuer iminothiazolidinderivate
ATA258985A (de) Verfahren zur herstellung von neuen substituierten 7-oxomitosanen
AT380477B (de) Verfahren zur herstellung von neuen spirothiazolidindion-derivaten
ATA253884A (de) Verfahren zur herstellung von neuen 4'-halogenanthracyclinglykosiden
AT377004B (de) Verfahren zur herstellung eines neuen komplexes eines polyaether-antibiotikums
AT371146B (de) Verfahren zur herstellung einer neuen antibiotischen substanz
AT384218B (de) Verfahren zur herstellung von neuen chinazolin-derivaten
AT371465B (de) Verfahren zur herstellung von neuen 2-azaergolinen und 2-aza-8(oder 9)-ergolenen
ATA298586A (de) Verfahren zur herstellung von neuen anthracyclinglykosiden
ATA106084A (de) Verfahren zur herstellung von neuen gonadoliberin-derivaten
ATA371584A (de) Verfahren zur herstellung neuer cephalosporanderivate
ATA284985A (de) Verfahren zur herstellung von neuen carbapenemderivaten
AT386407B (de) Verfahren zur herstellung von neuen n-sulfamyl -3-halogenpropionamidinen
AT381318B (de) Verfahren zur herstellung von neuen nitrosoharnstoffderivaten
AT377264B (de) Verfahren zur herstellung von neuen nitrosoharnstoffderivaten

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee